Diabetes Mellitus, a Risk Factor for Systemic Inflammatory Response Syndrome in Patients after Percutaneous Nephrolithotomy
DOI:
https://doi.org/10.70749/ijbr.v3i7.2130Keywords:
systemic inflammatory response syndrome, percutaneous nephrolithotomy, diabetes mellitusAbstract
Objective: The purpose of this study is to ascertain the prevalence of systemic inflammatory response syndrome in individuals with diabetes mellitus following PCNL. The findings of this study will assist in developing recommendations for these individuals in order to lower their morbidity and SIRS rate. Study design: Cohort study. Settings: Department of Urology, Madinah Teaching Hospital, Faisalabad. Study duration: February to April of 2025. Materials & Methods: Total 106 patients between the ages of 18 and 70 with unilateral kidney calculi receiving PCNL were included, regardless of gender. Patients who had received phase II PCNL were excluded, as were those with a history of cancer or hematologic disorders, a preoperative white blood cell count (WBC) of >12 * 109 cells/L or <4 * 109 cells/L, a preoperative basal body temperature of >38°C or <36°C, and a basal heart rate of >90 beats/min. A consultant with three years of post-fellowship experience performed PCNL on the patients under general anesthesia following a single intravenous injection of a preventive antibiotic regimen. SIRS was diagnosed in patients. Results: Following percutaneous nephrolithotomy, 17 (16.04%) of the patients in our study experienced systemic inflammatory response syndrome. Eleven (30.56%) of the 36 diabetic patients had SIRS developed, while 25 (69.44%) did not. Diabetes mellitus and SIRS were found to be significantly correlated (p 0.006), with DM patients having a higher odd ratio of 4.69 for SIRS development. Conclusion: One of the early side effects of PCNL surgery is SIRS, which can result in sepsis and septic shock, which can lengthen hospital stays, increase morbidity, and potentially increase mortality after the procedure.
Downloads
References
1. Santanapipatkul K. Factors associated with urosepsis following percutaneous nephrolithotomy. Insight Urol. 2021; 42:56-62.
https://doi.org/10.52786/isu.a.23
2. Mi Q, Meng X, Meng L, Chen D, Fang S. Risk factors for systemic inflammatory response Syndrome Induced by Flexible Ureteroscope combined with Holmium laser lithotripsy. Biomed Res Int. 2020; 2020:6842479.
https://doi.org/10.1155/2020/6842479
3. Zhou G, Zhou Y, Chen R, Wang D, Zhou S, Zhong J, et al. The influencing factors of infectious complications after percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2022;51(1):1-17.
https://doi.org/10.1007/s00240-022-01376-5
4. Liu J, Yang Q, Lan J, Hong Y, Huang X, Yang B. Risk factors and prediction model of urosepsis in patients with diabetes after percutaneous nephrolithotomy. BMC urology. 2021;21(1):74-82.
https://doi.org/10.1186/s12894-021-00799-3
5. Mishra A, Mittal J, Tripathi S, Paul S. Factors predicting infective complications following percutaneous nephrolithotomy and retrograde intrarenal surgery according to systemic inflammatory response syndrome and quick sequential organ failure assessment: A prospective study. Urol Ann. 2023; 15:295-30.
https://doi.org/10.4103/ua.ua_150_22
6. Ao P, Shu L, Zhuo D, et al. Risk factors associated with systemic inflammatory response syndrome after flexible ueteroscopic lithotripsy based on enhanced recovery after surgery. Zhonghua Yi Xue Za Zhi. 2019; 99:758–63.
7. Akdeniz E, Ozturk K, Ulu MB, Gur M, Caliskan ST, Sehmen E. Risk factors for systemic inflammatory response syndrome in patients with negative preoperative urine culture after percutaneous nephrolithotomy. J Coll Physicians Surg Pak. 2021: 31(04): 410-416.
https://doi.org/10.29271/jcpsp.2021.04.410
8. Shreedhar Khatavakar1, Mahesh MS2, Seuz C. Samson2, Shankar Gunadal. Assessment of Risk Factors of Systemic Inflammatory Response Syndrome Following Percutaneous Nephrolithotomy And Their Impact On Patient Outcomes. Int J Acad Med Pharm 2025; 7 (1); 739-744.
9. O’Connor CJ, Kinnear N, Browne G and Hennessey DB. Bilateral staghorn kidney stones in megacalycosis: non operative management of complex kidney stone disease. Urol Case Rep 2022; 44: 102146.
https://doi.org/10.1016/j.eucr.2022.102146
10. Scotland KB, Armas-Phan M, Dominique G and Bayne D. Social determinants of kidney stone disease: the impact of race, income and access on urolithiasis treatment and outcomes. Urology 2022;163:190-5.
https://doi.org/10.1016/j.urology.2021.08.037
11. Yusuf F, Elmekresh A, Kumar S and Bagheri F. Percutaneous nephrolithotripsy in morbidly obese patient: a case report. Case Rep Urol. 2022;2022:5899896.
https://doi.org/10.1155/2022/5899896
12. Rice P and Somani BK. Percutaneous laser nephrolithotripsy: is it here to stay? Results of a systematic review. Curr Opin Urol 2022; 32: 185-191.
https://doi.org/10.1097/mou.0000000000000959
13. Lotan P, Goldberg H, Nevo A, Darawsha AE, Gefen S, Criederman G, Rubinstein R, Herzberg H, Holland R, Lifshitz D and Golomb D. Post-operative pain following percutaneous nephron-lithotripsy-clinical correlates. Urologia 2022; 3915603221130899.
https://doi.org/10.1177/03915603221130899
14. Wang C, Xu R, Zhang Y, Wu Y, Zhang T, Dong X, Zhang R and Hu X. Nomograms for predicting the risk of SIRS and urosepsis after uroscopic minimally invasive lithotripsy. Biomed Res Int 2022; 2022: 6808239.
https://doi.org/10.1155/2022/6808239
15. Li GH, Zhao L, Lu Y, Wang W, Ma T, Zhang YX and Zhang H. Development and validation of a risk score for predicting postoperative delirium after major abdominal surgery by incorporating preoperative risk factors and surgical Apgar score. J Clin Anesth 2021; 75: 110408.
https://doi.org/10.1016/j.jclinane.2021.110408
16. Yoo JW, Lee KS, Chung BH, Kwon SY, Seo YJ, Lee KS and Koo KC. Optimal duration of preoperative antibiotic treatment prior to ureteroscopic lithotripsy to prevent postoperative systemic inflammatory response syndrome in patients presenting with urolithiasis-induced obstructive acute pyelonephritis. Investig Clin Urol 2021;62:681-89.
https://doi.org/10.4111/icu.20210160
17. Jentzer JC, Lawler PR, van Diepen S, Henry TD, Menon V, Baran DA, Dzavik V, Barsness GW, Holmes DR Jr and Kashani KB. Systemic inflammatory response syndrome is associated with increased mortality across the spectrum of shock severity in cardiac intensive care patients. Circ Cardiovasc Qual Outcomes. 2020;13:e006956.
https://doi.org/10.1161/circoutcomes.120.006956
18. Senlin Lan 1,#, Bohao Liu 2,#, Siwei Xie 3, Chunting Yang. Risk factors of systemic inflammatory response syndrome after minimally invasive percutaneous nephrolithotomy with a controlled irrigation pressure. BMC Urol. 2024 Dec 27;24:287.
https://doi.org/10.1186/s12894-024-01680-9
19. Aragon-Sanchez J, Viquez-Molina G, Lopez-Valverde ME and Rojas-Bonilla JM. Severe diabetic foot infections without systemic inflammatory response syndrome: prospective validation of a new category. Wound Repair Regen 2022; 30: 553-559.
https://doi.org/10.1111/wrr.13038
20. Donthiri SR, Shaik J, Guru Praveen APS, Ramesh ML, Reddy PV. Preoperative and intraoperative factors that influence development of systemic inflammatory response syndrome following percutaneous nephrolithotomy. Int J Res Med Sci 2025;13:137-42.
https://doi.org/10.18203/2320-6012.ijrms20244105
21. Alken P. Percutaneous nephrolithotomy - the puncture. BJU Int. 2022;129(1):17–24.
https://doi.org/10.1111/bju.15564
22. Raj K K, Adiga K P, Chandni Clara D'souza R, Nandakishore B Rajani Upadhyaya et al. (April 30, 2024) Prospective Evaluation of Risk Factors Responsible for Infection Following Retrograde Intrarenal Surgery. Cureus 16(4): e59420.
https://doi.org/10.7759/cureus.59420
23. Keerthana S1, Griffin M. Study of Role of Sirs Markers in Predicting Post Operative Sepsis in Patients Undergoing PCNL. Afr. J. Biomed. Res. Vol. 27(September 2024); 2670-2675.
24. Chen X, Li S, Shi C, Zhang W, Liu Z, Jiang J, Zhang Y, Chen Z, Zheng B, Zhu H. Risk factors and predictors of urogenous sepsis after percutaneous nephrolithotomy for idiopathic calcium oxalate nephrolithiasis. Transl Androl Urol 2023;12(6):1002-1015.
https://doi.org/10.21037/tau-23-219
25. Wen S, Deng F, Li L. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1- mediated pyroptosis and inflammation. J Diabetes Investig 2022;13:22-33.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
